Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Apricus Biosciences -- Ignore unavailable to you. Want to Upgrade?

To: mokelumne river who wrote (1816)	4/5/2016 12:40:04 PM
From: Mirror Image	Read Replies (1) \| Respond to of 2026

If we knew that for SURE Pfizer would aggressively market Vitaros if/when approved I would definitely be hoping for the Merger to go through. But we don't know for sure. Wouldn't you feel more secure with a company like Recordati marketing Vitaros in the U.S.? Not that I know who the other companies interested in possibly marketing Vitaros in the U.S. are. I do think that the chances of Vitaros being approved by the FDA are good. They might need more work ( possibly ) but ultimate approval chances are good in my book.